Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
This is a Phase II trial to study the effectiveness and security of cisplatin concurrent
chemoradiotherapy plus TIL versus cisplatin concurrent chemoradiotherapy only with IMRT in
treating patients with locoregionally advanced high risk nasopharyngeal carcinoma.